Drug firm Divi's Laboratories today posted a rise of 23 per cent rise in net profit at Rs 301.81 crore for the first quarter ended June 30.
The company had posted a net profit of Rs 245.18 crore for the same period of previous fiscal.
Net sales of the company rose to Rs 1,005.97 crore for the first quarter as compared to Rs 806.91 crore during the same period of previous financial year, Divi's Laboratories said in a regulatory filing.
The company manufactures active pharmaceutical ingredients (APIs) and intermediates.
Shares of the company today ended 1.35 per cent up at Rs 1,190.30 on BSE.
Disclaimer: No Business Standard Journalist was involved in creation of this content
